Información del producto
LY 215840 is a cyclase inhibitor that blocks the conversion of 5-hydroxytryptamine (5-HT) to serotonin, which is the final step in the synthesis of this neurotransmitter. LY 215840 has been shown to have glomerulosa activity and can be used in the treatment of thyroid disease and piperazine. LY 215840 also has atypical properties and can be used for the treatment of depression and anxiety disorders. It also has antagonistic effects on 5-ht4 receptors, which leads to an increase in serotonin levels in cells. LY 215840 also has an antagonist effect on melanocortin receptors, which leads to decreased appetite and weight loss.
Propiedades químicas
Consulta técnica sobre: 3D-MFA32852 LY 215840
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
